Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol

Blood

Volumn 99, Issue 8, 2002, Pages 2786-2793

  Jordà, Meritxell Alberich ^a,b   Verbakel, Sandra E ^a,b   Valk, Peter J M ^a,b   Vankan Berkhoudt, Yolanda V ^a,b   Maccarrone, Mauro ^a,b   Finazzi Agrò, Allessandro ^b   Löwenberg, Bob ^a,b   Delwel, Ruud ^a,b  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR; CHEMOATTRACTANT; ENDOCANNABINOID 2 ARACHIDONOYLGLYCEROL; IMMUNOGLOBULIN D; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL MIGRATION; EXON; GENE INSERTION; GENE LOCUS; HEMATOPOIETIC STEM CELL; LEUKEMIA CELL; LIGAND BINDING; MOUSE; MYELOID LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; PROTO ONCOGENE; RECEPTOR INTRINSIC ACTIVITY; SPLEEN CELL;

EID: 0037089221     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.8.2786     Document Type: Article

References (73)

1. Structure of a cannabinoid receptor and functional expression of the cloned cDNA
2. Molecular characterization of a peripheral receptor for cannabinoids
3. The genes encoding the peripheral cannabinoid receptor and α-L-fucosidase are located near a newly identified common virus integration site, Evi11
4. Retroviral insertions in Evi12, a novel common virus integration site upstream of Tra1/Grp94, frequently coincide with insertions in the gene encoding the peripheral cannabinoid receptor Cnr2
5. G protein-coupled receptor systems involved in cell growth and oncogenesis
6. Regulation of cell proliferation by G proteins
7. Mitogenic signaling via G protein-coupled receptors
8. G-protein-coupled receptor genes as protooncogenes: Constitutively activating mutation of the α 1B-adrenergic receptor enhances mitogenesis and tumorigenicity
9. Expression cloning of oncogenes by retroviral transfer of cDNA libraries
10. Ectopic expression of the serotonin 1c receptor and the triggering of malignant transformation
11. Activation of the mas oncogene during transfection of monoblastic cell line DNA
12. Isolation and characterization of a new cellular oncogene encoding a protein with multiple potential transmembrane domains
13. Receptors induce chemotaxis by releasing the βγ subunit of Gi, not by activating Gq or Gs
14. Genetic analysis of mammalian G-protein signalling
15. Stereochemical effects of 11-OH-8 8-tetra-hydrocannabinol-dimethylheptyl to inhibit adenylate cyclase and bind to the cannabinoid receptor
16. Determination and characterization of a cannabinoid receptor in rat brain
17. Cannabinoid receptors CB1 and CB2: A characterization of expression and adenylate cyclase modulation within the immune system
18. Aminoalkylindole binding in rat cerebellum: Selective displacement by natural and synthetic cannabinoids
19. Pharmacology and stereoselectivity of structurally novel cannabinoids in mice
20. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
21. 2-Arachi-donoylglycerol: A possible endogenous cannabinoid receptor ligand in brain
22. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
23. New dawn of cannabinoid pharmacology
24. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide
25. Correlation of cell-surface phenotype with the establishment of interleukin 3-dependent cell lines from wild-mouse murine leukemia virus-induced neoplasms
26. Touw IR Distinct cytoplasmic regions of the human granulocyte colony-stimulating factor receptor involved in induction of proliferation and maturation
27. Anandamide, a natural ligand for the peripheral cannabinoid receptor is a novel synergistic growth factor for hematopoietic cells
28. Isolation of cDNA clones encoding the β isozyme of human DNA topoisomerase II and localisation of the gene to chromosome 3p24
29. Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: Implications for receptor-mediated immune modulation by cannabinoids
30. Modulation and functional involvement of CB2 peripheral cannabinoid receptors during B-cell differentiation
31. The peripheral cannabinoid receptor, Cb2, in retrovirally-induced leukemic transformation and normal hematopoiesis
32. Interpreting cDNA sequences: Some insights from studies on translation
33. Initiation of translation in prokaryotes and eukaryotes
34. Translational pathophysiology: A novel molecular mechanism of human disease
35. Control of translation initiation in animals
36. Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism
37. Genetic mutations resulting in estrogen insufficiency in the male
38. G protein-coupled receptors and signaling pathways regulating growth responses
39. Cell growth control by G protein-coupled receptors: From signal transduction to signal integration
40. Molecular cloning and structure of a pre-B-cell growthstimulating factor
41. Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene
42. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)
43. Activation of HIV-1 coreceptor (CXCR4) mediates myelosuppression
44. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood
45. A differential role of extracellular signal-regulated kinase in stimulated PC12 pheochromocytoma cell movement
46. Sphingosine 1-phosphate stimulates cell migration through a G(i)-coupled cell surface receptor, Potential involvement in angiogenesis
47. Leukemic predisposition of Sca1/Cb2 transgenic mice
48. The endogenous cannabinold anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines
49. Cannabinoids inhibit LPS-inducible cytokine mRNA expression in rat microglial cells
50. Cannabinoid receptors and the cytokine network
51. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells
52. T lymphocyte migration: The influence of interactions via adhesion molecules, the T cell receptor, and cytokines
53. Chemokine and cytokine cooperativity: Eosinophil migration in the asthmatic response
54. Synergistic effect of granulocyte-macrophage colonystimulating factor and 1,25-dihydroxyvitamin D3 on the differentiation of the human monocytic cell line U937
55. Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor: Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells
56. Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor: Structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds
57. 2-Arachidonoylglycerol and the cannabinoid receptors
58. Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: Antagonism by anandamide
59. Analogues and homologues of N-palmitoylethanolamide, a putative endogenous CB2 cannabinoid, as potential ligands for the cannabinoid receptors
60. Cannabinoids enhance human B-cell growth at low nanomolar concentrations
61. Cannabinoid receptors and the regulation of immune response
62. Tetrahydrocannabinol-induced suppression of macrophage spreading and phagocytic activity in vitro
63. Cannabinoid inhibition of the processing of intact lysozyme by macrophages: Evidence for CB2 receptor participation
64. Peripheral blood lymphocyte subpopulations and mitogen responsiveness in tobacco and marijuana smokers
65. Intact humoral and cell-mediated immunity in chronic marijuana smoking
66. Altered serum immunoglobulin concentration in chronic marijuana smokers
67. δ 9-tetrahydrocannabinol selectively inhibits T-cell dependent humoral immune responses through direct inhibition of accessory T-cell function
68. Marijuana effects on immunity: Suppression of human natural killer cell activity of δ-9-tetrahydrocannabinol
69. Inhibition of natural killer cell function by marijuana components
70. δ 9-tetrahydrocannabinol modulates antigen processing by macrophages
71. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations
72. Cannabinoid-receptor expression in human leukocytes